THEDAILYDate:11Feb2021

TheDailyViewpoint

Page 2 Page 2

DOMESTICINDICES

Close Points %Change

SENSEX 51309 -20 -0.04

NIFTY 15107 -3 -0.02

MIDCAP 19810 140 0.71

SMALLCAP 19420 81 0.42

SECTORALINDICES

Close Points %ChangeREALTY 2795 47 1.72CD 33323 419 1.27

AUTO 24850 234 0.95Healthcare 21856 85 0.39METAL 12656 37 0.29

IT 25865 26 0.10Finance 7830 -2 -0.03OIL&GAS 14789 -4 -0.03

TECK 11878 -12 -0.10POWER 2246 -3 -0.14CG 22072 -109 -0.49

BANKEX 40461 -264 -0.65

BSE200GAINERS/LOSERS

GAINERS % LOSERS %MOTHERSUMI 7.93 NAM-INDIA -2.55MUTHOOTFIN 6.90 INDUSTOWER -2.40IBULHSGFIN 5.83 AARTIIND -2.14WHIRLPOOL 5.79 INDIGO -2.01PAGEIND 5.29 SANOFI -1.97

ADVANCE/DECLINES

BSE %ADVANCES 1465 47DECLINES 1499 48

UNCHANGED 161 5

INSTITUTIONALACTIVITY

RsCr 10/02/21 09/02/21 FebTotalFII 1787 1301 12630(prov.)DII -2076 -1756 -6607(prov.)

Indian markets could open lower, following largely negativeAsianmarketstodayandflatUSmarketsonWednesday..…U.S.stocksclosedmixed,thoughtheDowekedoutanewall-timehigh, after Federal Reserve Chairman Jerome Powell said heremained focused on getting Americans back to work anddownplayedtheriskofrunawayinflation.A report on U.S. inflation also showed investors have little toworry about, for now, giving a brief boost to stocks in earlytrade. The U.S. consumer price index rose 0.3% in January asexpected,afterclimbing0.4%amonthearlier.StockswereflatinearlytradinginAsiaonThursdayasinvestorskept tapping the brakes on runs in asset prices after taking intepidU.S.inflationdataandcommentsfromtheFederalReservechief affirming the outlook for a slow recovery.MultiplemajormarketsinAsiaareclosedforholidaysincludinginChina,Japan,SouthKoreaandTaiwan.Indian equity benchmark indices ended mildly lower after avolatile session on Feb 10. At close, the Nifty was down 2.80pointsor0.02%at15,106.50.Niftyafter falling initially, recovered in theafternoononFeb10andclosedneartheintradayhighs.Onedayup -onedaydownphenomenonmakes it tough to anticipate thenear term trend.Advancedecline ratiohasnowbecomealmostequal suggestingequality in bull and bear pressures. 15168-15257 band couldprovide resistance to theNiftywhile 14950-14977 could be thesupportband.Govttosell20%stakeinNationalFertilizersLtdthroughOFS:Thecentralgovernmenthasdecidedtosell20%stakeinNationalFertilizersLtd(NFL)throughanofferforsale.TheDepartmentofInvestment and Public Asset Management (DIPAM) has invitedtendersfrommerchantbanksforthesaleprocess.IRB InfrastructureDevelopers to raiseup toRs2,200 crore viaNCDissue:IRB Infrastructure Developers will raise up to Rs 2,220 crorethrough issuance of non-convertible debentures. The companyhas entered into a definitive agreementwith India Toll Roads -ForeignPortfolioInvestor,forraisingoffundsbyissuanceofnon-convertible debentures up to Rs 2,220 crore subject tosatisfactorycompletionofproceduralconditionsSIStoconsiderbuybackofequitysharesonFeb15:Board of directors meeting of the company will be held onFebruary 15, 2021, to consider and approve a proposal forbuyback of the equity shares of the company. Promoters’ hold73.34%stakeinthecompanyasonDec-2020.

TheDailyViewpoint

Page 3 Page 3

GLOBALINDICES

EXCHANGERATES

Value %Change

USD/INR 72.8 0.20

EURO/USD 1.212 0.03

USD/GBP 1.383 0.02

USD/JPY 104.6 0.00

COMMODITIES

Value %Gold($/Oz) 1838.2 -0.25Silver($/Oz) 26.9 -0.79

CrudeOilFutures 58.3 -0.63BrentOil($/Barrel) 61.1 -0.05

BONDYIELD

Value% ChgbpsIND10YrBondYield 6.010 -0.065

ADR

Value$ %DrReddysLabs 65.6 -0.49

HDFCBank 80.8 -0.88

ICICIBank 17.6 -0.62

TataMotors 22.2 -0.71

Wipro 6.58 -0.90

VedantaLtd 10.19 0.59

INFOSYS 17.51 -0.74

Adar Poonawalla-backed firm to acquire majority stake inMagmaFincorpforRs3,456cr:Rising Sun Holdings (RSH) Private Ltd, a company controlled bybillionaireAdarPoonawallahasagreedtoacquiremajoritystakein Magma Fincorp in a deal valued at Rs 3456 crore. MagmaFincorpsaidthatitwillissuepreferentialshareswhichwillresultinRSHpickingup60%stakeinthenon-bankingfinancecompany.ThedealalsoincludesanopenofferasperSEBInorms.RoyalEnfieldmaylookathikingpricesagaininApril:Niche bike maker Royal Enfield may look at hiking prices fromApril in viewof rising commodity prices, a top company officialsaid on Wednesday. The company, which is a part of EicherMotors,hasalready increasedpricesbymultiple timesover thelastsixmonths."Commoditypriceshavegoneup,wehavetriedtooffsetitbymultiplethingsincludingpricehikesinthelastfewmonths.Wewillprobablybe increasingpricesagain inApril likeeveryoneelse inthe industry,"RoyalEnfieldCEOVinodKDasaritoldreporters.VodafoneIdea’s4GspeedfastestamongtelcosinOct-Dec,saysOokla:VodafoneIdeaLtd’s(Vi)4Gwirelessservice, includingdownloadanduploadspeeds,wasthefastestamongtelecomoperators inIndia during October-December, as per Ookla, a web serviceprovider that tests global internet speeds.With this, Vi becamethe only operator to have delivered the fastest speedsconsistentlyinthepastsixmonthsacrossthecountry.Hiring activity remains stable in January 2021: MonsterEmploymentIndex:HiringactivityhasremainedstableinIndiainJanuary2021,asperMonster Employment Index, a job analysis report byMonster.com,aQuesscompany.TheindexhasbeenstablesinceNovember 2020, as hiring activity remained consistent with aneutraltrendinthelastquarter.However,therehasbeenayear-on-yeardeclineof18percentasofJanuary2021comparedtothepreviousyearduetotheimpactofthepandemic.IncomparisontoJanuary2020, jobpostingsinsomeindustrieshaveimproved,withsomedoingevenbetterthanthepre-COVID-19levels.ProposaltomakevehiclesE20fuelcompliantby2025:TheCentre is“activelyconsidering”aproposal tomakevehiclescompliantwithE20fuelby2025,inlinewithitsplantopromotealternateandgreenfuels.E20fuel isgasolineblendedwith20%ethanol.Theroadtransportandhighwaysministryisworkingontheproposal,andamechanismforsuchcompliancewillbeputinplacegradually,aseniorgovernmentofficialsaid.TCStohire1,500techemployeesinUKinnextoneyear:TataConsultancyServices(TCS), India's largestsoftwareservicesfirm,willrecruit1,500technologyemployeesintheUKoverthenext year. The announcement followed Monday’s meeting inMumbai between visiting UK Trade Secretary Liz Truss and TCSCEO, Rajesh Gopinathan, where they discussed the company’scommitment to continue investing in the UK’s economy,innovation,technologysector,andindevelopingworkforceskills.

Close Points %ChgDOWJONES 31438 61.97 0.20

S&P500 3910 -1.35 -0.03

NASDAQ 13973 -35.16 -0.25

FTSE 6524 -7.20 -0.11

CAC 5671 -20.74 -0.36

DAX 13933 -78.83 -0.56

NIKKEI 29563 57.00 0.19

SHNAGAI 3655 51.60 1.43

HANGSENG 29859 -179.47 -0.60

BOVESPA 118435 -1036.29 -0.87

TheDailyViewpoint

Page 4 Page 4

EicherMotorsQ3FY21ResultUpdate:Revenuesjumped18.6%overtheyearearliertoRs2,804croreasunitsalesrose5%overtheyearagoto1.99lakhunitsintheDecemberendedquarter.Itsexportsjumped44.4%to12,234unitsduringtheperiod.EBITDArose10.6%yoytoRs595crorewhilemarginscontracted172bpsto25.2%.NetprofitforthemakerofRoyalEnfieldmotorcycleswasflatyoyatRs488crore.SuprajitEngineeringQ3FY21ResultUpdate:Consolidated revenues for the quarter increased by 23% yoy to Rs 507cr driven by 26.2% growth in India business.EBITDAforthequartercameinatRs86crup72.9yoywhileEBITDAmarginsexpanded491bpsto17%.PATstoodatRs52cranincreaseof65.6%yoy.Thecompanyhasapprovedtheproposaltobuyback15lakhsharesatRs320/-eachanddeclaredaninterimdividendofRe0.75/-AurobindoPharmaQ3FY21ResultUpdate:Consolidated revenue for the quarter grew8% yoy at Rs 6365cr.US formulations revenue increased 6.8% yoy at Rs3172cr. Europe formulation business registered 13.2% yoy growth at Rs 1671cr. ARV revenue increased 41.5% at Rs443cr.GlobalgenericInjectablesalesforQ3FY21wasUS$109mnandfor9MFY21itstoodatUS$283mn.EBITDAmargin improved100bpsyoyat21.5%.Otherexpenses increased17%yoyatRs1543cr.Netprofitexcludingexceptionalitemsincreased17%yoyatRs837cr.OtherIncomesurgedtoRs133.4crasagainstRs31cr,ayearagoonforeignexchangegain.Financecostdeclined45%yoyatRs19.5cr.ReportedPATforthequarterwasatRs2946.5crasitincludedoneoffgainofRs2814cr.ItincludedRs3093crduetodisposalofbusinessassetsofNatrolLLC,USA.CompanyhastakenRs432crimpairmentchargestowardsproductrelatedintangiblesandgoodwill.R&DexpensesforthequarterstoodatRs391cror6.1%ofrevenues.Companyfiled8productsandreceivedapprovalfor13ANDAsfromUSFDAincluding9injectables.AsonDec2020,onacumulativebasis,thecompanyfiled634ANDAswithUSFDAandreceivedapprovalfor463ANDAsincluding29tentativeapprovals.Overall,thecompanyhasfilingsfor141injectableANDAsand54awaitapprovalfromUSFDA.NetcashincludinginvestmentsattheendofDecember2020stoodatUS$117mn.Aurobindo’svaccinespipelineconsistsofbacterialandviralvaccines.CompanyisdevelopingPneumococcalConjugateVaccine(PCV)vaccinethroughitsJointVenturewithTergenebiotech.It isdevelopingviralvaccinesinHyderabadandthroughitswholly-ownedstepdownsubsidiary,AuroVaccinesinUS.JBChemicals&PharmaceuticalsQ3FY21ResultUpdate:Revenue for thequarter increased27.7%yoyatRs548cr.Domestic formulationbusinessgrew26%yoyatRs232cr.Internationalbusinessregistered31%yoyincreaseatRs299crledbystronggrowthfromexportformulationrevenues.EBITDAmarginexpanded1030bpsyoyat31.2%duetoloweremployeecostsandotherexpenditure.Companysaidthatoperatingmargin iselevatedand includethecontributionfromrevenuesdeferredfromQ2FY21 intoQ3FY21.Otherexpensesweredown1%atRs105.6cr.Strongrevenue,robustmarginandhigherother income ledtosharpsurge inprofitability.NetprofitforthequartercameinatRs154.3crascomparedtoRs66.4cr,ayearago.OtherIncomesurgedto Rs 56cr as it included Rs 34cr as one-off gain on sale of product registration,marketing authorisation alongwithtrademark.BoardhasdeclaredRs8.5pershareasinterimdividendforFY21.Companyhas5brandsamongtop-300brandsinIndianPharmaMarket(IPM).AsonDec-2020,thecompanyhad1617MRsandmonthlyrevenueperMRstoodatRs4.4lakhsascomparedtoRs3.6lakhsinFY20.TitanCompanyQ3FY21ResultUpdate:Titan Company has reported numbers above expectation in Q3FY21. Revenue for the quarter stood at Rs. 7619cr,+17/67%YoY/QoQ.EBIDTA for thequarter stoodatRs.848cr,+12/171%YoY/QoQ.PAT for thequarter stoodatRs.530cr,+12/206%YoY/QoQ.

TheDailyViewpoint

Page 5 Page 5

EBITDAMargincontractedby0.5%YoYandexpandedby4%QoQto11.1%.PATMargincontractedby0.31%YoYandexpandedby3.16%QoQto7%.EPSforthequarterstoodatRs.5.92,+11/201%YoY/QoQ.StockiscurrentlytradingatP/E183x;EV/EBIDTA93.38xTheCompany'sretailchain(includingCaratLane)standsat1,854stores,ason31stDecember2020witharetailareacrossing2.4millionsq.ft.forallitsbrandscovering292towns.RevenueofWatchessegmenthasposted12%y-o-ydegrowthtoRs.551crandEBITofthissegmentdegrowsby62%y-o-y to Rs.15cr of loss. Revenue of the Jewellery segment has posted 22% y-o-y growth to Rs.6836cr and EBIT of thissegmentgrownby9%y-o-ytoRs.766crofloss.RevenueoftheEyewearsegmenthasposted7%y-o-ydegrowthtoRs.124crandEBITofthissegmenthasturnedtoprofitofRs.22crfromlossofRs.7crinQ3FY20.3MIndiaQ3FY21ResultUpdate:Revenueofthecompanyposteddegrowthby1%y-o-ytoRs.741cr.Thenetprofitofthecompanyhasposteddegrowthby18%y-o-ytoRs.59crfromRs.72crinthesamequarterpreviousyear.RevenueofSafety&Industrialthesegmenthasposted1%y-o-ydegrowthtoRs.281crandEBITofthissegmentdegrowby1%y-o-ytoRs.38cr.RevenueofTransportation&Electronicsthesegmenthasposted7%y-o-ygrowthtoRs.271crandEBITofthissegmentdeclinedby11%y-o-ytoRs.11cr.RevenueofHealthCarethesegmenthasposted23%y-o-ydegrowthtoRs.93crandEBITofthissegmentdegrowby3%y-o-ytoRs.13cr.RevenueofConsumerthesegmenthasposted10%y-o-ygrowthtoRs.88crandEBITofthissegmentdegrowby36%y-o-y toRs.11cr.Revenueofother segmenthasposted21%y-o-ygrowth toRs.8crandEBITof thissegmentgrowby70%y-o-ytoRs.3cr.SpiceJetQ3FY21ResultUpdate:Revenueof thecompanyposteddegrowthby54%y-o-y toRs.1692cr.Thecompanyhaspostedanet lossofRs.67crfromanetprofitofRs.78crinthesamequarterpreviousyear.Registeroverallloadfactorof77.9%includingdomestic&internationaloperationsofthecompany.GujaratStatePetronetLtd(GSPL)Q3FY21ResultUpdate:GSPLnumbersaboveexpectation inQ3FY21.Company’sphysicaland financialperformance reflecta strong recoveryafterthesecondquarterduetogradualeasingofrestrictions.Consolidatednetrevenuewasdownby7.3%YoYtoRs580croreinQ3FY21.EBITDAwasupby4.8%YoYtoRs398.4crore.EBITDAmarginwasupat68.7%inQ3FY21vs.60.7%inQ3FY20.NetProfitgrew11.4%YoYtoRs247.5croreinQ3FY21.PATmarginincreasedto42.7%inQ3FY21vs.35.5%inQ3FY20.Company's transmission volume declined, sequentially from 39.75 mmscmd in Q2FY21 to 39.36 in Q3FY21. While,transmissionvolumewasuponYoYbasisfrom36.94mmscmdinQ3FY20.OnSectorwisevolume,onethirdvolumecomesfromCGDsectorandalmostonefourthvolumefromPowersector,andrestfromrefinery/petchem,fertilisersandothers,ason31stDec2020.IndraprasthaGasLtd(IGL)Q3FY21ResultUpdate:IGL numbers were almost at par with the expectation in Q3FY21, Company’s physical and financial performancereflectedastrongrecoveryafterthesecondquarterduetogradualeasingofrestrictions.Consolidatednetrevenuewasdownby13.1%YoYtoRs1446.2croreinQ3FY21.However,itwasupby10.8%onasequentialbasis,aftercitygassalesrecoveredaftereasingofcoronaviruslockdownrestrictions.EBITDAwasupby27.8%YoYtoRs500.7crore.EBITDAmarginwasat34.6%inQ3FY21vs.23.5%inQ3FY20.NetProfitgrew28.4%YoYtoRs381.8croreinQ3FY21.PATmarginincreasedto26.4%inQ3FY21vs.17.9%inQ3FY20.Company's gas sales volume declined, sequentially. During the current quarter, in the CNG category, the gas salesvolumewasdownby9%QoQto412SCMMillion.Invaluetermsitwasdownby15.1%QoQtoRs1029croreinQ3FY21.

TheDailyViewpoint

Page 6 Page 6

InthePNGcategory,thedomesticgassalesvolumewasupby14%QoQ,to41SCMMillion,industrial/Commercialgassalesvolumewasupby2%QoQandNaturalGaswasdownby15%QoQto39SCMMillion.Invalueterms,itwasdownby9%QoQtoRs409croreinQ3FY21.GAIL(India)LtdQ3FY21ResultUpdate:GAIL(India)Ltd.reportedaboveexpectationnumbersinQ3FY21,robustrecoveryinrevenueandprofitabilityacrossthesegments,sequentially.Consolidatednetrevenuewasdownby12.4%YoYandupby13.5%QoQtoRs15,663.6croreinQ3FY21.Company'soperationswereimpactedonYoYbasis,duetonationwidelockdownimposedbytheGovernmentofIndiainviewofCOVID-19.EBITDAwasupby3.4%YoYand57.8%QoQtoRs2,244.5crore.EBITDAmarginwasupat14.3%inQ3FY21vs.12.1%inQ3FY20and10.3%inQ2FY21.NetProfitwasdownby6.5%YoYtoRs1,897.0croreinQ3FY21.PATmarginincreasedto12.1%inQ3FY21vs.11.3%inQ3FY20.Company's Transmission services for Natural Gas and LPG increased 4.6% QoQ to Rs 1788.9 crore. Petrochemicalsrevenuegrew15%QoQtoRs1936crore,whilethenaturalgasmarketingsegmentsawanincreaseof13%QoQtoRs14882.7crore.TheLPGandliquidhydrocarbonsgrew9.3%QoQtoRs877.9crore.MetropolisHealthcareQ3FY21ResultUpdate:Revenue for the quarter stood at Rs 274.78cr +23.3%/-4.7% YoY/QoQ. EBITDA for the quarter stood at Rs. 86.6cr+36.3%/-4.6%YoY/QoQ.EBITDAMarginexpanded300bps/flatYoY/QoQandstoodat31.5%.PATforthequarterstoodatRs58.57cr+39.2%/-2.8%YoY/QoQ.EPSforthequarterstoodatRs11.50Non-covidrevenuecontinuestogaintractionandachievedpositivegrowthduringthequarter.Covidrelatedrevenuemay continue tomoderateand couldbecomeoneof the routine tests.Betterproductmix, costoptimisationeffortsalongwithautomation&digitizationenhancedEBITDAmargins inQ3FY21ascomparedtosameperiodlastyear.ThecompanydeclaredinterimdividendofRs.8/-perequityshareforFY21andfixedFeb19,2021astherecorddate.AshokLeylandQ3FY21resultpreview:Revenueisexpectedtogrow71/21%QoQ/YoY,fromalowbasetoRs4840cr.Volumesforthequartercameinat33kunits (+72/7%QoQ/YoY) ledby strongdemand in the LCV segment.EBITDAmargin isexpectedat5.4% (-21bpsYoY,+250bpsQoQ).WeexpectthecompanytoreportaprofitofRs44crafterreporting lossfortwoconsecutivequarter.Market share gains in the LCV segment, AL’s diversification initiatives and recovery trends inMHCVs would be keymonitorables.PetronetLNGLtd.Q3FY21resultpreview:PetronetLNGcouldreportrevenuefallby25%YoYtoRs6,680croreandCompanycouldreportnetprofitgrowthof1%YoYtoRs680croreinQ3FY20.WeexpecttotalvolumecouldbeflatonYoYbasisbutitcouldfallby6-8%at233tbtuinQ3FY20.CommentsonproductionstatusfromDabholterminalandKotchiterminalandannouncementofnewprojectswillbekeytowatch.Importantnews/developmentstoinfluencemarketsØ  JapanPPIforJanuary-1.6%y/y(expected-1.6%),+0.4%m/mexpected0.4%,prior0.5%m/m.

Ø  China’sconsumerpriceindex(CPI),amaingaugeofinflation,declined0.3percentyearonyearinJanuary,comparedwitha0.2-percentincreaseinDecemberlastyear.

Ø  China's factory-gate prices swung to growth in January, ending an 11-month period of deflation as the industrialsectorcontinuedtoleadthenation'seconomicrecovery.

Ø  GermanFinalCPIinJanuarycameinatastrong0.8%,confirmingtheinitialestimate.

Ø  U.S. Consumer Price Index rose 0.3% in January, after a 0.4% rise in December. The data in linewith consensusforecasts.

Ø  UScommercialcrudeoilinventoriesdropped-6.6mbarrelsintheweekendingFebruary5,smallerthanexpectationof-0.9mbarrels.

TheDailyViewpoint

Page 7

Daily Technical View on Nifty

Observation:Marketsended flatonWednesdayafterarecoveryfromthelowsinthelastonehouroftradehelped to erase the intra day losses. TheNifty finallyshed2.8pointsor0.02%tocloseat15,106.5.

Broadmarket indices like theBSEMidCap and SmallCapindicesgainedmore, therebyoutperformingtheSensex/Nifty. Market breadth was negative on theBSE/NSE.

ZoomingintotheNifty15mincharts,weobservethatthe Nifty opened on a weak note and gradually slidlower.Atonepointoftime,theNiftywastrading132pointslowerasitmovedbelowourtargetsof15015.

A smart recovery from the lows in the lateafternoonsession helped the index to erase themorning lossesandcloseonaflatnote.Therecoveryledtotheindexclosingabovethe20and50periodmovingaverageonthe 15 min chart. The strength seen in the lateafternoon session could therefore carry over in theverynearterm.

Onthedaily chart,wecanobservethattheNiftyhasconvincinglyreversedtherecentdowntrendbymovingup froma trend line supportandconvincingly closingabovethe50daySMAlastMonday.Withtheuptrendintact,theNiftynowcomfortablytradesabovethe20daySMA.Whiletherecouldbecorrectionsintheverynearterm,weexpecttheindextomakenewlifehighsinthecomingsessions.

ItisimportantthattheNiftydoesnotmovebelowthesupportof14864onanycorrectionsfortheshorttermuptrendtoremainintact.

Conclusion: The1-2daytrendoftheNiftyisnowupwith the Nifty recovering strongly from the lows ofWednesday and closing above the 50 period movingaverageontheintradaychart.Niftyislikelytotestthe15260levelsintheverynearterm.Our7-dayviewonthe market too remains bullish as the Nifty hasconvincinglyreversedtherecentdowntrendbymovingup froma trend line supportandconvincingly closingabovethe20dayand50daySMA.Ourbullishbetsforthe next 7 sessions would be off if the Nifty moveslowerandclosesbelowthe14864levels.

Nifty View for 1-2 days

Reversal 7-Day View

Reversal

15107 Bullish 14977 Bullish 14864

Target 15260

Target 15400

Nifty – Daily Timeframe chart

Nifty – Intraday 15 min. chart

TheDailyViewpoint

Page 8 Page 8

SHORT TERM TRADING CALLS

NO. RECO DT. RECO COMPANY NAME ENTRY CMP SL TARGET 1

TARGET 2 UPSIDE % VALID TILL

1 7-JAN-21 BUY NESCO* 563.0 594.0 516.0 610.0 675.0 14 7-APR-21

2 11-JAN-21 BUY KAVERI SEEDS 545.8 521.3 503.0 591.0 650.0 25 11-APR-21

3 12-JAN-21 BUY CONTAINER CORP* 441.4 500.3 400.0 484.0 560.0 12 11-JUL-21

4 28-JAN-21 BUY BIOCON* 384.3 408.2 352.0 415.0 450.0 10 28-APR-21

5 2-FEB-21 BUY HEG LTD* 1016.8 1217.5 900.0 1150.0 1300.0 7 1-AUG-21

6 2-FEB-21 BUY PVR 1569.7 1498.8 1400.0 1750.0 2000.0 33 1-AUG-21

7 3-FEB-21 BUY REDINGTON* 147.6 162.1 136.0 162.0 188.0 16 2-AUG-21

8 5-FEB-21 BUY SPICE JET 90.1 87.9 82.5 100.0 112.0 27 6-MAY-21

9 8-FEB-21 BUY LAURAS LAB 346.2 359.3 311.0 388.0 440.0 22 9-MAY-21

10 8-FEB-21 BUY INDIAN HOTEL 122.5 126.9 113.0 134.0 150.0 18 9-MAY-21

11 10-FEB-21 BUY IDFC LTD 45.7 47.2 40.6 51.5 58.0 23 11-MAY-21

OPEN CASH POSITIONAL CALLS

*= 1st Target Achieved

NO. RECO DT. RECO COMPANY NAME ENTRY CMP SL TARGET UPSIDE % VALID TILL

1 10-FEB-21 BUY CUMMIN 800 FEB CALL OPTION 31.3 31.8 21.0 50 57 17-FEB-21

2 5-FEB-21 BUY AUROBINDO FEB FUT 940-954 970.0 925.5 982.5 1 12-FEB-21

3 10-FEB-21 BUY AMARAJA BATTERIES FEB FUT 977.30-951 990.2 947.5 1007.5 2 15-FEB-21

4 10-FEB-21 BUY TATA CHEMICALS FEB FUT 561.15 979.6 549.0 577 -41 12-FEB-21

5 8-FEB-21 BUY L&T 1557.60-1500 1552.9 1485.0 1660 7 17-FEB-21

6 9-FEB-21 BUY DECCAN CEMENT 379-386 391.9 374.0 414 6 23-FEB-21

7 10-FEB-21 BUY DHANI 349-357.25 361.3 344.0 383 6 24-FEB-21

TheDailyViewpoint

Page 9 Page 9

OPEN DERI POSITIONAL CALLS

NO. RECO DT. RECO COMPANY NAME ENTRY CMP SL TARGET 1 TARGET 2 UPSIDE % VALID TILL

1 2-FEB-21 BUY UPL FEB FUT* 557.3 537.0 527.0 570.0 600.0 12 TILL 25TH FEB 21

2 3-FEB-21 BUY SRF FEB FUT 5697.6 5560.8 5400.0 6020.0 6400.0 15 TILL 25TH FEB 21

3 4-FEB-21 BUY MC DOWELL FEB FUT 592.0 575.8 560.0 620.0 660.0 15 TILL 25TH FEB 21

4 8-FEB-21 BUY CIPLA FEB FUT 858.7 865.2 790.0 922.0 960.0 11 TILL 25TH FEB 21

5 9-FEB-21 BUY SBI LIFE MARCH FUT 884.8 916.3 855.0 921.0 954.0 4 TILL 25TH MAR 21

6 10-FEB-21 SELL BPCL FEB FUT 397.0 401.7 431.0 355.0 - 12 TILL 25TH FEB 21

NO. RECO DT. RECO COMPANY NAME ENTRY CMP SL TARGET 1 TARGET 2 UPSIDE % VALID TILL

1 14-NOV-20 BUY MAS FINANCIAL SERVICE* 930.0 879.1 820.0 1040.0 1150.0 31 14-MAY-21

2 23-NOV-20 BUY BATA INDIA* 1464.0 1569.1 1330.0 1630.0 1850.0 18 23-MAY-21

3 5-JAN-21 BUY ATUL LTD 6454.0 6339.9 6000.0 6920.0 7254.0 14 5-APR-21

4 5-JAN-21 BUY FINOLEX CABLE* 358.8 369.4 320.0 402.0 450.0 22 5-APR-21

5 2-FEB-21 BUY MHRIL 228.8 232.1 201.0 261.0 295.0 27 2-MAY-21

6 3-FEB-21 BUY TRENT 668.3 690.9 611.0 735.0 - 6 3-MAY-21

7 8-FEB-21 BUY EIH HOTEL 97.3 97.4 89.5 108.0 - 11 8-MAY-21

8 8-FEB-21 BUY SAIL 67.7 66.7 60.0 76.0 84.0 26 8-MAY-21

9 10-FEB-21 BUY BLUE DART 4603.0 4713.4 4190.0 5160.0 5500.0 17 10-MAY-21

OPEN E-MARGIN POSITIONAL CALLS

*= 1st Target Achieved

TheDailyViewpoint

Page 10 Page 10

DATA&EVENTS

QUARTERLYRESULTSANNOUNCED

COMPANY Q3FY21 YoY(%) QoQ(%) Remarks

Sales(RsCr)

NP(RsCr) Sales NP Sales NP

SpiceJet 1692 -67 -54 PL 58 LL InlineExpectationTitanCompany 7619 530 17 12 67 206 AboveExpectation

3MIndia 741 59 -1 -18 7 -21 BelowExpectationGAIL(India)Ltd 15663.6 1897.0 -12.4 -6.5 13.5 77.6 AboveExpectationIndraprasthaGas 1446.2 381.8 -13.1 28.4 10.8 0.4 InlineExpectation

GSPL 580.0 247.5 -7.3 11.4 0.5 -8.7 AboveExpectationMetropolisHealthcareLtd 274.78 58.57 23.3 39.2 -4.7 -2.8 BelowEstimates

EicherMotorsLtd. 2804.1 488.5 18.6 -0.1 32.1 35.4 AsperexpectationsSuprajitEngineeringLtd. 507.3 51.6 23.0 65.6 14.5 7.4 Aboveexpectations

PL:ProfittoLoss,LP:LosstoProfit,LL:LosstoLoss

TheDailyViewpoint

Page 11 Page 11

Disclaimer:This report has been prepared by HDFC Securities Ltd and is meant for sole use by the recipient and not for circulation. Theinformationandopinionscontainedhereinhavebeencompiledorarrivedat,basedupon informationobtained ingood faith fromsourcesbelievedtobereliable.Suchinformationhasnotbeenindependentlyverifiedandnoguaranty,representationofwarranty,expressorimplied,ismadeastoitsaccuracy,completenessorcorrectness.Allsuchinformationandopinionsaresubjecttochangewithout notice. This document is for information purposes only. Descriptions of any company or companies or their securitiesmentionedhereinarenotintendedtobecompleteandthisdocumentisnot,andshouldnotbeconstruedasanofferorsolicitationofanoffer,tobuyorsellanysecuritiesorotherfinancialinstruments.Thisreportisnotdirectedto,orintendedfordisplay,downloading,printing,reproducingorfordistributiontooruseby,anypersonorentitywhoisacitizenorresidentorlocatedinanylocality,state,countryorotherjurisdictionwheresuchdistribution,publication,reproduction,availabilityorusewouldbecontrarytolaworregulationorwhatwouldsubjectHSLoritsaffiliatestoanyregistrationorlicensingrequirementwithinsuchjurisdiction.If this report is inadvertently send or has reached any individual in such country, especially, USA, the samemay be ignored andbrought to theattentionof the sender.Thisdocumentmaynotbe reproduced,distributedorpublished foranypurposeswithoutpriorwrittenapprovalofHSL.Foreign currencies denominated securities, wherever mentioned, are subject to exchange rate fluctuations, which could have anadverseeffectontheirvalueorprice,ortheincomederivedfromthem.Inaddition,investorsinsecuritiessuchasADRs,thevaluesofwhichareinfluencedbyforeigncurrencieseffectivelyassumecurrencyrisk.Itshouldnotbeconsideredtobetakenasanoffertosellorasolicitationtobuyanysecurity.HSLmayfromtimetotimesolicitfrom,orperformbroking,orotherservicesfor,anycompanymentionedinthismailand/oritsattachments.HSLanditsaffiliatedcompany(ies),theirdirectorsandemployeesmay;(a)fromtimetotime,havealongorshortpositionin,andbuyorsellthesecuritiesofthecompany(ies)mentionedhereinor(b)beengagedinanyothertransactioninvolvingsuchsecuritiesandearnbrokerageorothercompensationoractasamarketmakerinthefinancialinstrumentsofthecompany(ies)discussedhereinoractasanadvisororlender/borrowertosuchcompany(ies)ormayhaveanyotherpotentialconflictofinterestswithrespecttoanyrecommendationandotherrelatedinformationandopinions.HSL,itsdirectors,analystsoremployeesdonottakeanyresponsibility,financialorotherwise,ofthelossesorthedamagessustainedduetotheinvestmentsmadeoranyactiontakenonbasisofthisreport, includingbutnotrestrictedto,fluctuationinthepricesofsharesandbonds,changesinthecurrencyrates,diminutionintheNAVs,reductioninthedividendorincome,etc.HSLandothergroupcompanies, itsdirectors,associates,employeesmayhavevariouspositions inanyofthestocks,securitiesandfinancialinstrumentsdealtinthereport,ormaymakesellorpurchaseorotherdealsinthesesecuritiesfromtimetotimeormaydealinothersecuritiesofthecompanies/organizationsdescribedinthisreport.HSLor itsassociatesmighthavemanagedorco-managedpublicofferingofsecurities for thesubjectcompanyormighthavebeenmandatedbythesubjectcompanyforanyotherassignmentinthepasttwelvemonths.HSLoritsassociatesmighthavereceivedanycompensationfromthecompaniesmentionedinthereportduringtheperiodprecedingtwelvemonths from t date of this report for services in respect ofmanaging or co-managing public offerings, corporate finance,investment banking or merchant banking, brokerage services or other advisory service in a merger or specific transaction in thenormalcourseofbusiness.HSLoritsanalystsdidnotreceiveanycompensationorotherbenefitsfromthecompaniesmentionedinthereportorthirdpartyinconnectionwith preparation of the research report. Accordingly, neither HSL nor Research Analysts have anymaterial conflict ofinterest at the time of publication of this report. Compensation of our Research Analysts is not based on any specific merchantbanking, investment banking or brokerage service transactions. HSLmay have issued other reports that are inconsistentwith andreachdifferentconclusionfromtheinformationpresentedinthisreport.Research entity has not been engaged inmarketmaking activity for the subject company. Research analyst has not served as anofficer,directororemployeeofthesubjectcompany.Wehavenotreceivedanycompensation/benefitsfromthesubjectcompanyorthirdpartyinconnectionwiththeResearchReport.HDFC securities Limited, SEBI Registration No.: INZ000186937 (NSE, BSE, MSEI, MCX) |NSE Trading Member Code: 11094 | BSEClearingNumber:393|MSEITradingMemberCode:30000|MCXMemberCode:56015|IN-DP-372-2018(CDSL,NSDL)|CDSLDPID:12086700|NSDLDP ID: IN304279|AMFIRegNo.ARN-13549|PFRDAReg.No -POP11092018| IRDACorporateAgentLicenceNo.CA0062|ResearchAnalystReg.No.INH000002475|InvestmentAdviser:INA000011538|CIN-U67120MH2000PLC152193RegisteredAddress: IThinkTechnoCampus,Building,B,Alpha,OfficeFloor8,NearKanjurmargStation,Kanjurmarg(East),Mumbai-400042.Tel-02230753400.ComplianceOfficer:Ms.BinkleROza.Ph:022-30453600,Email:complianceofficer@hdfcsec.com.MutualFundsInvestmentsaresubjecttomarketrisk.Pleasereadtheofferandschemerelateddocumentscarefullybeforeinvesting.